NeueHealth (NeueHealth) Interest Expense : $-33 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is NeueHealth Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. NeueHealth's interest expense for the three months ended in Mar. 2024 was $ -3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-33 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. NeueHealth's Operating Income for the three months ended in Mar. 2024 was $ -23 Mil. NeueHealth's Interest Expense for the three months ended in Mar. 2024 was $ -3 Mil. NeueHealth did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NeueHealth Interest Expense Historical Data

The historical data trend for NeueHealth's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeueHealth Interest Expense Chart

NeueHealth Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-7.23

-12.82

-38.20

NeueHealth Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial														-7.79	-9.17	-10.04	-11.21	-2.93

NeueHealth Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-33 Mil.

NeueHealth (NYSE:NEUE) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NeueHealth's Interest Expense for the three months ended in Mar. 2024 was $-3 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-23 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $66 Mil.

NeueHealth's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

NeueHealth did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

NeueHealth (NeueHealth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » NeueHealth Inc (NYSE:NEUE) » Definitions » Interest Expense

Comparable Companies

PFHO MRAI UNH ELV CI CVS HUM CNC MOH SZSE:000503 ALHC BSP:ODPV3 OSCR CLOV BSP:QUAL3 ROCO:6665 MIL:HI TSXV:NXG

Traded in Other Exchanges

N/A

Address

8000 Norman Center Drive, Suite 900, Minneapolis, MN, USA, 55437

Website

https://www.brighthealthgroup.com

Bright Health Group Inc is a technology-enabled, value-driven healthcare company focused on delivering affordable healthcare to the fast-growing aging and underserved populations in Florida, Texas, and California. It consists of two reportable segments: Bright HealthCare includes delegated senior managed care business that partners with a tight group of aligned providers in California focused on serving aging and underserved populations with unmet clinical needs through a Fully-Aligned Care Model, and Consumer Care includes a value-driven care delivery business that manages risk in partnership with external payors, It aims to significantly reduce the friction and current lack of coordination between payors by delivering on its Fully-Aligned Care Model with multiple payors.

Executives

Mikan George Lawrence Iii	director, officer: CEO and President	200 SW 1ST AVE, SUITE 1600, FORT LAUDERDALE FL 33301
Jay Matushak	officer: Chief Financial Officer	C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 900, MINNEAPOLIS MN 55437
Jeffrey S Cook	officer: CEO, NeueHealth	C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437
Jeffrey J Scherman	officer: Chief Accounting Officer	C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 1200, MINNEAPOLIS MN 55437
Cathy R Smith	officer: CFO & CAO	TARGET CORPORATION, 1000 NICOLLET MALL, TPS-3155, MINNEAPOLIS MN 55403
Jeff Michael Craig	officer: GC & CORPORATE SECRETARY	C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437
Manuel Kadre	director	2020 SALZEDO STREET, SUITE 301, CORAL GABLES FL 33134
Jeffrey R Immelt	director	GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Nea 18 Vge Gp, Llc	10 percent owner	C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea Partners 18 Vge, L.p.	10 percent owner	C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea 18 Venture Growth Equity, L.p.	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea 17 Gp, Llc	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea Partners 17, L.p.	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
New Enterprise Associates 17, L.p.	10 percent owner	1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Michael A Carson	officer: CEO, Bright HealthCare	C/O BRIGHT HEALTH GROUP INC., 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437